The urokinase receptor is overexpressed in the AIDs dementia complex and other neurological manifestations
- 25 March 2004
- journal article
- research article
- Published by Wiley in Annals of Neurology
- Vol. 55 (5) , 687-694
Abstract
The urokinase‐type plasminogen activator (uPA) and its receptor (uPAR) play an important role in extracellular matrix degradation and cell migration in the central nervous system (CNS). To investigate the role of the uPA/uPAR system in the pathophysiology of acquired immunodeficiency syndrome dementia complex (ADC), we measured soluble uPAR (suPAR) levels in cerebrospinal fluid (CSF) and plasma from human immunodeficiency virus (HIV)‐1–infected patients and controls. CSF suPAR levels were significantly higher in HIV‐1–infected patients than in controls and in patients with ADC or opportunistic CNS infections (CNS‐OIs) than in neurologically asymptomatic patients, irrespective of HIV‐1 disease stage. The highest levels of suPAR were found in patients with ADC, and among those with CNS‐OIs in patients with cytomegalovirus encephalitis or cryptococcosis. Plasma suPAR levels were higher in HIV‐1–infected patients than in controls and increased with HIV‐1 disease stage regardless of the presence of CNS disease. In patients with ADC or CNS‐OIs, CSF suPAR levels correlated with CSF HIV‐1 RNA, but not with plasma suPAR concentrations. Highly active antiretroviral therapy was associated with a significant and parallel decrease of both CSF suPAR and HIV‐1 RNA. In brain tissue from patients with HIV‐1 encephalitis, uPAR was highly expressed by microglial and multinucleated giant cells staining positively for HIV‐1. The overexpression of uPAR in the CNS of patients with ADC suggests that the uPA/uPAR system may contribute to the tissue injury and neuronal damage in this disease. Ann Neurol 2004Keywords
This publication has 26 references indexed in Scilit:
- uPAR: a versatile signalling orchestratorNature Reviews Molecular Cell Biology, 2002
- Amino-Terminal Fragment of Urokinase-Type Plasminogen Activator Inhibits HIV-1 ReplicationBiochemical and Biophysical Research Communications, 2001
- Etiology of microglial nodules in brains of patients with acquired immunodeficiency syndromeJournal of NeuroVirology, 2000
- Urokinase Plasminogen Activator Receptor (uPAR; CD87) Expression on Monocytic Cells and T Cells is Modulated by HIV-1 InfectionImmunobiology, 1998
- Acquisition of host cell-surface-derived molecules by HIV-1AIDS, 1996
- Regulation of Integrin Function by the Urokinase ReceptorScience, 1996
- Enhancement of the Enzymatic Activity of Single-chain Urokinase Plasminogen Activator by Soluble Urokinase ReceptorJournal of Biological Chemistry, 1995
- TIMP-2 reduces proteolytic opening of blood-brain barrier by type IV collagenaseBrain Research, 1992
- Nomenclature and research case definitions for neurologic manifestations of human immunodeficiency virus‐type 1 (HIV‐1) infectionNeurology, 1991
- HIV‐Associated Disease of the Nervous System: Review of Nomenclature and Proposal for Neuropathology‐Based TerminologyBrain Pathology, 1991